PRA ICR Documents
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
ICR Documents
Supporting Statement A
Document
Date Uploaded
Supporting Statement A 1.15.25.docx
01/16/2025
Supporting Statement B
Document
Date Uploaded
Supplementary Documents
Title
Document
Document Type
Date Uploaded
Public Comments
Author Name
Comment Document
Author Affiliation
Sponsoring Org.
Type
Category
Date of Comment
Date Comment Received
Asay, Derek
Comment 2_Asay (full).pdf
Comment 2_Asay (transmittal).pdf
Eli Lilly and Company
Email
Simple
10/07/2024
10/07/2024
Santo, Corbin
Comment 3_Santo (full).pdf
Comment 3_Santo (transmittal).pdf
Pharmaceutical Research and Manufacturers of America (PhRMA)
Email
Simple
10/07/2024
10/07/2024
Junger, James
Comment on 340B ADR Information Collection Review.pdf
PC_202501-0906-002_021425_063914_1.pdf
Other -- Reginfo.gov
Simple
02/14/2025
02/14/2025
Godon, Stephanie
Comment 1_Gordon.pdf
340B PC / Director of Pharmacy
Email
Simple
08/23/2024
08/23/2024
Asay, Derek
PC_202501-0906-002_021425_025928_1.pdf
HRSA ADR ICR Comment 2.14.25.pdf
Eli Lilly and Company
Other -- Reginfo.gov
Simple
02/14/2025
02/14/2025
Testoni, Maureen
Comment 4_Doggett (transmittal).pdf
Comment 4_Testoni (full).pdf
340B Health
Email
Simple
10/07/2024
10/07/2024
Franks, Angie
Comment 5_Kalderos (full).pdf
Comment 5_Kalderos (transmittal).pdf
Kalderos
Email
Simple
10/07/2024
10/07/2024
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.